TrialEuropean journal of nuclear medicine and molecular imaging2004

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours.

Andreas Helisch et al.PubMed ↗Publisher ↗

No numbers read from the abstract.